Suchergebnisse - "Uterine Cervical Neoplasms"

PubPharm (3.571)

1

Breast and cervical cancer programs' success in maintaining screening during periods of high COVID-19 : A qualitative multi-case study analysis

enthalten in: Heliyon | 2024

von Schlueter, D. | Bermudez, Y. | Debrot, K. | +5

2

Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values : a promising tool for patient´s immunotherapy selection

enthalten in: European radiology | 2024

von Liu, K. | Yang, W. | Tian, H. | +2

3

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions : A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

enthalten in: ClinicalTrials.gov | 2024

4

Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama : Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama

enthalten in: ClinicalTrials.gov | 2024

5

A Study of SGN-B6A in Advanced Solid Tumors : A Phase 1 Study of SGN-B6A in Advanced Solid Tumors

enthalten in: ClinicalTrials.gov | 2024

6

Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer : A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer

enthalten in: ClinicalTrials.gov | 2024

7

Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate : Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rate: The BASICS Trial

enthalten in: ClinicalTrials.gov | 2024

8

Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) : A Registry-Based Extension of Protocol V503-001 in Countries With Centralized Cervical Cancer Screening Infrastructures to Evaluate the Long-Term Effectiveness, Immunogenicity, and Safety of Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine as Administered to 16- to 26- Year-Old Women

enthalten in: ClinicalTrials.gov | 2024

9

Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa : Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa

enthalten in: ClinicalTrials.gov | 2024

10

Breast and Cervical Cancer Education Program : OWEL Cancer Education and Awareness Program (OCEAP)

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[358]